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SUMMARY – Th e purpose of the study was to assess the level of serum malondialdehyde (MDA) 
concentration and its association with the stage and histopathologic sizes of colorectal cancer (CRC). 
One hundred and two patients having undergone surgical treatment of CRC between January 2014 
and December 2015 were included in this cross-sectional study. Th e patients were divided into four 
groups (stage I-IV) according to the TNM classifi cation. Control group included 30 subjects with no 
signs of malignancy and infl ammatory diseases. In each patient, preoperative blood samples were ob-
tained for determination of MDA concentration by ELISA immunoassay. Serum levels of MDA were 
progressively increased in patients with CRC, reaching the highest value in the fourth stage of CRC. 
Serum concentrations of MDA were signifi cantly higher in pT4 group as compared with pT3 and 
pT2 groups of CRC patients (p<0.01). Signifi cantly higher levels of MDA were found in the N1 and 
N2 groups of CRC patients as compared with N0 group, as well as in patients with metastatic disease 
as compared with those without metastasis (p<0.001). In conclusion, the progression of CRC is as-
sociated with a signifi cant increase in serum MDA levels.
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Introduction
Colorectal cancer (CRC) is a neoplastic process 
that occurs in colon tissue. Th ere are about one million 
new cases diagnosed each year, making CRC the third 
most common malignant tumor in human pathology 
around the world and the second leading cause of 
death due to malignant disease1.
Colorectal cancer is a heterogeneous disease that 
occurs in only partially known complex sequence of 
molecular events. Oxidative stress is one of the mecha-
nisms involved in the process of carcinogenesis. It is 
known that reactive oxygen compounds cause oxida-
tive modifi cation of nucleotide bases in the DNA (e.g., 
oxidation of thymine, cytosine, adenine and guanine), 
which can lead to carcinogenesis through the muta-
genic potential of modifi ed nucleotide bases2. Th e re-
active intermediates, produced by oxidative stress, alter 
the structure of the membrane and cause lipid peroxi-
dation of polyunsaturated fatty acids (PUFAs). Free 
radicals incurred during lipid peroxidation have some 
local eff ects due to its short life but their degradation 
products may serve as ‘oxidative stress second messen-
gers’ due to the longer half-life and their ability to dif-
fuse from the place of their origin. Th ese decomposi-
tion products, mainly aldehydes such as malonalde-
hyde, hexanal, 4-hydroxynonenal or acrolein, gain a lot 
of attention because they are the most reactive com-
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pounds3,4. Malondialdehyde (MDA) is one of the most 
common and most harmful products of lipid peroxida-
tion, which may lead to cell damaging, reacting with 
the free amino groups of proteins and nucleic acids, 
with the target mutagenic activity at the site of gua-
nine in the DNA sequence5,6. Th erefore, determination 
of MDA can be used to estimate the intensity of oxi-
dative stress or damage caused by lipid peroxidation.
Th e role of oxidative stress in the pathogenesis and 
development of human CRC is suggested in diff erent 
reports. Gastrointestinal tract is particularly suscepti-
ble to an attack by reactive oxygen species that lead to 
carcinogenesis. However, information about the bio-
chemical alterations in the tissue and blood and their 
correlation with clinical stage of the disease is lacking7. 
Th e aim of the study was to analyze the concentration 
of MDA in the serum of patients in various CRC 
stages and to determine the relationship between this 
biomarker and stages, as well as histopathologic sizes 
of CRC estimated on the basis of preoperative, intra-
operative and histologic fi ndings (TNM classifi ca-
tion), and to determine whether MDA has predictive 
signifi cance in disease progression compared to histo-
pathologic fi ndings obtained after surgical resection of 
the tumor altered organ.
Materials and Methods
Th e cross-sectional study involved 102 patients of 
both genders with histologically confi rmed CRC, ad-
mitted between January 2014 and December 2015 at 
the Department of General and Abdominal Surgery, 
Sarajevo Clinical Center, University of Sarajevo, for 
surgical-oncologic treatment of CRC. Patients with 
evidence of neoplasm on an organ that was not linked 
to CRC, patients with an active infection, and patients 
with connective tissue diseases were excluded from the 
study. Based on the CRC stages, patients were divided 
into four groups: stage I (10 patients), stage II (30 pa-
tients), stage III (33 patients) and stage IV (29 pa-
tients). Determining the stage of colorectal neoplasms 
was carried out by the TNM staging system, using 
standard radiological examinations: chest x-ray, ultra-
sound (US) and computed tomography (CT) of the 
abdomen and, if necessary, other radiological imaging. 
Control group consisted of 30 patients of the appro-
priate age and gender, without clinical and laboratory 
signs of malignant or infl ammatory disease. Th e study 
protocol was approved by the local Ethics Committee. 
Th e study was carried out following the Declaration of 
Helsinki. A written informed consent was obtained 
from all patients.
Malondialdehyde concentration was analyzed at 
the Center for Cytogenetics and Molecular Medicine, 
Faculty of Medicine in Sarajevo, from serum samples 
(100 mL serum per sample) using a competitive en-
zyme immunoassay (ELISA). Preoperative blood 
samples were obtained and all serum samples were 
stored at -80 °C until analysis. Testing was performed 
using a commercial kit for estimation of the overall 
level of MDA (USCN Life Science Inc., US-CE-
A597GE, Houston, USA). Reading of the results is 
carried out at 450 nm on a plate reader STAT FAX 
2100 (USA). Th e measured MDA concentration was 
expressed in nanograms per milliliter (ng/mL).
Surgical treatment of CRC was performed as part 
of the therapeutic process. Th e oncologic surgery prin-
ciple of en bloc resection of the organ with associated 
lymph-vascular arcade was performed.
After macroscopic examination of the gut sample 
obtained by surgical resection, samples of the tumor 
mass and lymphatic nodes were collected for micro-
scopic analysis, which included determination of the 
histologic type of malignancy (categorization according 
to the World Health Organization), the depth of tumor 
invasion in the intestinal wall (pT), and the number of 
lymph nodes infi ltrated with cancerous tissue (pN). 
CRC stages were determined according to the TNM 
classifi cation of the American Committee for Cancer 
(American Joint Committee on Cancer, AJCC) in 
2010, in which “T” marks the degree of the intestinal 
wall invasion, “N” the level of lymph node involvement, 
and “M” means metastasis and spread staging; staging of 
the tumor is marked with numbers from I to IV.
Statistical analyses were performed by the Med-
Calc Software for Windows, version 12.6.1.0 (Mar-
iakerke, Belgium). Th e normality of data distribution 
was determined by Kolmogorov-Smirnov test. Con-
tinuous variables were presented as mean ± standard 
deviation (SD) and compared by using the t-test for 
independent samples when showing normal distribu-
tion. Mann-Whitney U test was used for results not 
displaying normal distribution or for comparison of 
nonparametric data. ANOVA and Kruskal-Wallis test 
were used for statistical evaluation of more than 3 
groups. Multiple regression analysis was used to exam-
I. Rašić et al. Serum malondialdehyde and colorectal cancer
Acta Clin Croat, Vol. 57, No. 3, 2018 413
ine the impact of MDA on the stage, depth of CR-
wall invasion (pT) and carcinoma infi ltration of lymph 
nodes. Th e level of signifi cance was set at p<0.05.
Results
Th e mean age of CRC patients (60% male and 40% 
female) was 66.2 (range 47-78) years, with no statisti-
cally signifi cant diff erence between male and female 
patients (65.04 vs. 64.3 years). Th e largest number of 
CRC patients were in the ≥70 age group (43.1%), fol-
lowed by the 61-70 age group (31.4%). Table 1 depicts 
characteristics of the study patient population.
Th e most common site of colon cancer was the rec-
tum area (34 patients, 33.3%), followed by the sigmoid 
colon (22 patients, 21.5%), while the least common 
area was the cecum (2.9%). Adenocarcinoma was con-
fi rmed histologically in all patients with colon cancer, 
of which grade 2 was most common (70.6% of pa-
tients). Concerning depth of the intestine wall inva-
sion, 18 (17.7%) patients had tumors involving the 
muscularis propria (pT2), 59 (57.8%) patients had 
 tumors involving the serosa without involvement of 
other organs (pT3), while 25 (24.5%) patients had the 
tumor that penetrated the visceral peritoneum (pT4).
Compared to the regional lymph nodes, metastases 
in 1-3 regional lymph nodes (N1) were found in 35 
(34.3%) patients, metastases in 4 or more regional 
lymph nodes (N2) in 25 (24.5%) patients, while no 
lymph node tumor process was observed in 42 (41.2%) 
patients. Distant metastases were found in 29 (28.4%) 
patients, mostly liver metastasis (26 patients).






Age (years), median (min, max) 54.1 (41-78) 66.2 (47-78) 0.041
Gender, n (%):
Male 14 (46.7%) 61.2 (60%) -
Female 16 (52.3%) 40.8 (40%)
Localization of CRC Cecum 3 (2.9%) -
Ascendens 15 (14.7%) -
Transversum 3 (2.9%) -
Descendens 6 (5.9%) -
Sigmoid 22 (21.5%) -
Rectosigmoid 19 (18.6%) -
Rectum 34 (33.3%) -
Histologic classifi cation Adenocarcinoma
grade I 11 (10.8%) -
grade II 72 (70.6%) -
grade III 14 (13.7%) -
grade IV 5 (4,9%) -
Depth of CR-wall invasion pT2 18 (17.7%) -
pT3 59 (57.8%) -
pT4 25 (24.5%) -
Lymph node invasion N0 42 (41.2%) -
N1 35 (34.3%) -






Data are presented as median (min, max), absolute numbers and percentages; MDA = malondialdehyde; 
CRC = colorectal cancer
I. Rašić et al. Serum malondialdehyde and colorectal cancer
414 Acta Clin Croat, Vol. 57, No. 3, 2018
Malondialdehyde, a product of lipid peroxidation, 
as an indicator of oxidative activity was monitored 
during the progression of CRC. It was confi rmed that 
the MDA concentration increased during progression 
of the malignant diseases of the colon, especially in its 
third stage (Table 2). In comparison to the control 
group, serum concentration of MDA did not diff er 
signifi cantly in the fi rst CRC stage (47.5 (16.5-58.3 
vs. 36.7 (13.1-58.7) ng/mL, p>0.05), but it was sig-
nifi cantly higher in the CRC second stage (p<0.05). In 
the third stage of the disease, serum MDA concentra-
tion was signifi cantly higher as compared to the sec-
ond stage (p<0.01), but not signifi cantly diff erent 
compared to the fourth stage of the disease (Table 2).
Th e recorded dynamics of change of this parameter 
according to depth of CR-wall invasion (pT) indicat-
ed that serum MDA concentration was signifi cantly 
higher in pT4 group as compared to pT3 group 
(p<0.01) and pT2 group of CRC patients (p<0.05), 
while there was no diff erence in serum MDA level be-
tween pT2 and pT3 groups of CRC patients (Table 2).
Th e mean levels of MDA were low in patients with 
no lymph node infi ltration by cancerous tissue (N0 
group). A higher MDA level was recorded in N1 group 
Table 2. Malondialdehyde concentration in patients with colorectal cancer
Characteristic MDA (ng/mL) p


















51.7 (17-59) 62.7 (55.8-69.4)* 65.35 (59.2-71)**
Metastatic disease M0 M1
<0.001
57.4 (40.9-66.6) 66.25 (60.8-69.5)
Data are presented as median and interquartile range; *p<0.01, diff erence between stages II and III and between N0 and N1; ap<0.05, 
 diff erence between stages I and III; **p<0.01, diff erence between stages II and IV and between N0 and N1; bp<0.05, diff erence between 
stages I and IV; **p<0.01, diff erence between pT3 and pT4; cp<0.05, diff erence between pT2 and pT4; MDA = malondialdehyde; 
CRC = colorectal cancer
Table 3. Independent predictors of colorectal cancer progression
B SE Beta t p
CI 95.0%
lower higher
Constant -1.711 0.692 -2.472 0.015 -3.083 -0.339
MDA 0.022 0.004 0.324 5.772 0.000 0.014 0.029
Dependent variable: CRC stage
Constant 2.782 0.985 2.825 0.006 0.824 4.740
MDA 0.011 0.003 0.378 3.418 0.001 0.005 0.017
Dependent variable: depth of CR-wall invasion (pT)
Constant -2.143 1.149 -1.865 0.066 -4.426 0.141
MDA 0.015 0.004 0.382 3.967 0.000 0.007 0.022
Dependent variable: carcinoma infi ltration of lymph nodes
Constant -1.114 0.635 -1.753 0.083 -2.377 0.149
MDA 0.004 0.002 0.188 2.109 0.038 0.000 0.008
Dependent variable: presence of metastasis
SE = standard error; CI = confi dence interval; MDA = malondialdehyde; CRC = colorectal cancer
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as compared to N0 group of CRC patients (p<0.001), 
while there was no signifi cant diff erence in serum con-
centration of MDA between the N1 and N2 groups 
(Table 2).
Analysis of MDA in serum of CRC patients sug-
gested that the mean concentration of the oxidative 
stress biomarkers was signifi cantly higher in patients 
with metastatic disease than in those without metasta-
sis (57.4 (40.9-66.6) vs. 66.25 (60.8-69.5) ng/mL, 
p<0.001).
Th e multivariate regression analysis showed that 
serum MDA concentration was an independent risk 
factor for the stage of CRC, as well as an independent 
positive predictor of the depth of CR-wall invasion 
(pT), carcinoma infi ltration of lymph nodes, and the 
presence of metastasis (Table 3).
Discussion
Colorectal cancer is one of the leading causes of 
death worldwide. Five-year survival is about 90% in 
patients with early stages of cancer, but decreases to 
less than 10% in patients with distant metastases8. In 
addition, 25% to 40% of patients undergoing curative 
surgery for localized CRC have a relapse or develop 
metastases.
Controlling CRC is performed by well-known 
clinical prognostic factors, including age, gender, can-
cer embryonic antigen biomarker, tumor diff erentia-
tion, tumor stage, lymphovascular invasion, perineural 
invasion, and lymph nodes. Th e fact is that today’s 
clinical-pathologic indicators cannot predict the out-
come of the disease. Th erefore, in recent years, signifi -
cant eff orts have been made to fi nd new markers of 
prognosis and selective approach to therapy.
Due to the high presence of lipids in the cell mem-
brane and membrane subcellular organelles, they are 
the site where oxidative damage to lipids begins. Lipid 
peroxidation results in a variety of degradation prod-
ucts, including MDA, which is an indicator of lipid 
peroxidation and oxidative stress. Th e target site of 
MDA action is guanine in DNA, which can cause mu-
tagenic damages, and evidence indicates that they may 
contribute to cancer, including CRC9. Results by 
Skrzydlewska et al. point that the products of lipid 
peroxidation, such as MDA, are increased in CRC tis-
sue10. Tahan et al.11 and Liu et al.12 found in animal 
models that the levels of MDA were signifi cantly in-
creased in colitis, infl ammation, and even before CRC 
development, and that the use of antioxidants could 
alleviate the severity of colitis by reducing the MDA 
concentration. Th e research by Leung et al. suggests 
that the concentration of MDA in serum is much 
higher in patients with advanced unresectable CRC 
than in those with primary localized CRC13.
In our study, measuring serum MDA concentra-
tion in patients with various CRC stages we found the 
concentration of this oxidative stress marker to signifi -
cantly increase to the third stage of the disease and as 
such persisted into the fourth stage of the disease. 
Similar results have been reported by Surinenaite et al., 
who found the concentration of MDA in serum of pa-
tients with CRC to be signifi cantly higher in the third 
stage of the disease as compared to the second stage, 
and to have decreased signifi cantly after surgical treat-
ment when compared with the preoperative level14.
In relation to the depth of tumor invasion (pT), 
signifi cantly higher levels of MDA were recorded in 
serum of pT4 group patients as compared to pT3 and 
pT2 groups, indicating oxidative stress increase with 
the increase in the histopathologic tumor size. Serum 
MDA was also confi rmed as a signifi cant independent 
positive predictor of the depth of tumor invasion in 
the intestinal wall, and an independent positive pre-
dictor of lymph node infi ltration by cancer tissue, as 
well as the occurrence of metastatic disease. All these 
facts suggest a high cytotoxic potential of MDA, 
which allows it to act as a carcinogenic agent and pro-
moter of CRC development and progression. Gopčević 
et al. found that lipid peroxidation increased in all 
CRC stages as compared to the control group, but 
with no signifi cant diff erences among the stages of the 
disease15. Recent studies point out that the oxidative 
status expression is caused by reduction of the poten-
tial antioxidant defense16.
Conclusion
A signifi cant increase in serum concentrations of 
MDA in relation to the CRC stage, depth of CR-wall 
invasion and presence of metastatic disease indicates a 
connection of MDA with carcinogenesis and progres-
sion of CRC. Assessing the level of oxidative stress 
expression by measuring serum MDA concentration 
could be useful in monitoring the eff ects of treatment 
of CRC, which can be the subject of future research.
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Sažetak
ODNOS IZMEĐU SERUMSKE RAZINE MALONDIALDEHIDA 
I PROGRESIJE KOLOREKTALNOG KARCINOMA
I. Rašić, A. Rašić, G. Akšamija i S. Radović
Cilj istraživanja bio je procijeniti razinu koncentracije malondialdehida (MDA) u serumu i njegove povezanosti sa stadi-
jem i histopatološkom veličinom kolorektalnog karcinoma (CRC). Stotinu i dva bolesnika podvrgnuta kirurškom liječenju 
CRC između siječnja 2014. i prosinca 2015. godine bili su uključeni u ovu presječnu studiju. Bolesnici su bili podijeljeni u 
četiri skupine (stadiji I.-IV.) prema klasifi kaciji TNM. Kontrolnu skupinu predstavljalo je 30 ispitanika bez znakova malignih 
i upalnih bolesti. U svakog bolesnika prijeoperacijski su uzeti uzorci krvi za određivanje koncentracije MDA pomoću imuno 
testa ELISA. Razine MDA u serumu su se postupno povećavale u bolesnika s CRC, dosegnuvši najvišu vrijednost u četvrtoj 
fazi CRC. Serumske koncentracije MDA bile su značajno više u skupini pT4 u odnosu na skupine pT3 i pT2 bolesnika s 
CRC (p<0,01). Utvrđene su značajno više razine MDA u skupinama N1 i N2 u odnosu na skupinu N0, kao i kod bolesnika 
s metastatskom bolešću u usporedbi s bolesnicima bez metastaza (p<0,001). U zaključku, napredovanje CRC povezano je sa 
značajnim porastom razine MDA u serumu.
Ključne riječi: Kolon, tumori; Oksidativni stres; Malondialdehid; Presječno istraživanje
